180-Day Exclusivity Is An “Incentive,” Not A “Right,” FTC Says
The Federal Trade Commission is calling 180-day generic exclusivity an "incentive," not a "right," in a filing with FDA opposing a citizen petition submitted by Ivax
The Federal Trade Commission is calling 180-day generic exclusivity an "incentive," not a "right," in a filing with FDA opposing a citizen petition submitted by Ivax